This one-day symposium will cover the new discoveries, challenges, and lessons in the development of RNAI screening technologies. The agenda features speakers from Alnylam Pharmaceuticals, the Massachusetts Institute of Technology, Novartis Institutes for Biomedical Research, and New York University.